Adia Nutrition Appoints Dr. Richard Edwards as Medical Director
Adia Nutrition (OTC Pink: ADIA) has appointed Dr. Richard Edwards, DO, as its second Medical Director, a move aimed squarely at improving patient care and accelerating clinical readiness. He joins Medical Director Dr. Monica Sher, MD, adding depth and perspective to a growing bench of medical leadership. The appointment supports the company’s plan to expand access to innovative treatments, with a particular focus on autologous Hematopoietic Stem Cell Transplantation (aHSCT).
Meet Dr. Edwards: Patient-First, Osteopathic Perspective
Dr. Edwards is known for patient-centered care, an approach that aligns with Adia Nutrition’s values and day-to-day practice. His training in osteopathic medicine complements the current medical board, strengthening the team’s capacity to shape care plans that look at the whole person—not just a diagnosis. That added perspective is meant to help the team design individualized treatment plans that consider specific health needs, preferences, and clinical circumstances.
Refining aHSCT Protocols, Together
As part of his role, Dr. Edwards will work closely with a board of oncologists to refine and implement aHSCT protocols. Drawing on the global experience base—more than 10,000 patients have been treated worldwide—the team will focus on best practices that emphasize safety and consistency. A key part of that work is selecting the right care setting for each step of treatment, whether that’s an outpatient clinic or a hospital, while maintaining the highest standards of care throughout.
What’s Next at Adia Nutrition
The company is actively recruiting experienced oncologists to further advance its aHSCT program. Each new oncologist will join the medical board and participate in rigorous candidate reviews. Those evaluations will rely on detailed medical histories and individual treatment needs so that every prospective patient is considered carefully and fairly. The goal is simple: match each candidate with the most appropriate and beneficial treatment options available.
CEO’s Perspective
“We are excited to have Dr. Edwards on board,” said Larry Powalisz, CEO of Adia Nutrition. “His profound knowledge and unique osteopathic insights will significantly enhance our Medical Division. This pivotal appointment will expedite our goal of launching our first treatment clinic,” he added. The message is clear: Adia Nutrition sees this as a practical step toward building clinical programs that can serve eligible patients well.
Staying Focused on Medical Excellence
Adia Nutrition remains committed to advancing care where it can make the most difference. Bringing Dr. Edwards into the team—and continuing to add oncologists—marks tangible progress toward that aim. With these additions, the company is positioned to develop and introduce refined protocols and to deliver aHSCT to qualified patients under careful oversight.
About Adia Nutrition Inc.
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) focused on quality and innovation across two operating divisions. One supplies high-quality, organic dietary supplements. The other concentrates on advanced medical treatments, including aHSCT for conditions such as Multiple Sclerosis (MS). Through this dual focus, Adia Nutrition Inc. works to help people make informed choices about their health and, where appropriate, access specialized care.
Frequently Asked Questions
What will Dr. Richard Edwards do as Medical Director?
Dr. Edwards will serve as the second Medical Director, working alongside Dr. Monica Sher and the broader medical board to strengthen patient care and refine treatment methods, including aHSCT.
Which treatments are a priority for Adia Nutrition?
The company is prioritizing autologous Hematopoietic Stem Cell Transplantation (aHSCT), with attention to patients who may benefit, including some with Multiple Sclerosis and other conditions.
Why is Adia Nutrition recruiting oncologists?
Oncologists will help build, validate, and implement safe and effective aHSCT protocols. Their expertise supports careful candidate evaluation and tailored treatment planning.
How will Adia Nutrition ensure treatment quality and safety?
The medical board, including Dr. Edwards, will draw on globally recognized practices and the worldwide experience base to review and refine protocols so best practices are followed.
How can I reach Adia Nutrition for more information?
For media inquiries or general questions, contact Larry Powalisz at ceo@adiamed.com or call 321-788-0850.
